Ellen Relkin, attorney and co-lead counsel in the New Jersey Ozempic lawsuits on NAION vision loss, shares exclusive insight and guidelines for anyone taking a GLP-1 medication.

An FDA panel's July vote didn't make BPC-157 legal to compound. Here's what that means for the cost of peptide therapy.

Novo Nordisk shares fell 22% year-to-date as US semaglutide sales slipped and CagriSema missed a Phase III goal; Q3 results ...

The interest in fashion and the fashion economy is not going so well right now, with people choosing to spend their money on ...

Dear reader, in July 2026, the two companies that dominate the world's most valuable class of medicines went to court against ...

Your skincare shelf probably already has a serum or two. Maybe a vitamin C for glow, maybe a hyaluronic acid for that dewy, just-left-the-facialist look. But the serum world just got a major glow-up.

"Her resume went into the reject pile. It was a great day. The only thing that could have made it happier is if she could ...

Researchers at the University of Auckland went looking for one thing in a familiar New Zealand fruit and found another. They ...

The successes of the GLP-1 class for chronic weight management “introduced consumer overlay over a historically physician-driven therapeutic area,” Pothier explained, noting that despite the potency ...

A new Vivek Ramaswamy ad responding to Amy Acton makes three unsupported claims about his pharmaceutical record, a ...

The arrest of the former head of Germany's external espionage agency raises the wider question of who we can trust ...

This article contains affiliate links, and we may earn a commission on qualifying purchases at no extra cost to you. This is educational content, not medical advice, and QMAX is a compounded ...